source
- Parabilis CEO Mathai Mammen on biotech's record IPOParabilis Medicines cemented the largest biotech IPO in industry history on Wednesday with its $670 million debut on the Nasdaq. But the Cambridge, MA-based drug developer won't be celebrating at t…Endpoints · 1mo ago↗ source
- Ethyreal starts up with $101M and takes aim at a pair of immune diseasesThe startup is developing a medicine that works differently than available treatments for thyroid eye disease and could benefit people with a related condition, too.BioPharma Dive · 1mo ago↗ source
- Novartis and Orionis strike second molecular glue deal for $40M upfrontNovartis is doubling down on its partnership with Orionis Biosciences in a deal worth $40 million upfront and up to $1.4 billion spread across milestones. The Boston and Belgian biotech will ...